Cargando…

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications

A significant number of patients with asthma remain uncontrolled despite treatment with inhaled corticosteroids (ICS) and long‐acting β2 adrenergic bronchodilators (LABA). The addition of long‐acting antimuscarinic agents (LAMA) can improve the management of asthma in these patients. Recently, three...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agusti, Alvar, Fabbri, Leonardo, Lahousse, Lies, Singh, Dave, Papi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290056/ https://www.ncbi.nlm.nih.gov/pubmed/34478578 http://dx.doi.org/10.1111/all.15076

Ejemplares similares

Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER
por: Singh, Dave, et al.
Publicado: (2020)

Camillo Sitte y el nacimiento del urbanismo moderno
por: Collins, George R. 1917-1993 (George Roseborough)
Publicado: (1980)

K sitt m tön selitys LHC n ongelmille
Publicado: (2009)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Sonographic Identification of Tube Thoracostomy Study (SITTS): Confirmation of Intrathoracic Placement
por: Jenkins, Jamie A., et al.
Publicado: (2012)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
por: Singh, Dave, et al.
Publicado: (2019)

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Facchinetti, Fabrizio, et al.
Publicado: (2021)

Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
por: Zheng, Jinping, et al.
Publicado: (2021)

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
por: Singh, Dave, et al.
Publicado: (2019)

When single-inhaler triple therapy is a preferred option in asthma management?
por: Al-Moamary, Mohamed S., et al.
Publicado: (2022)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Impact of triple therapy on mortality in COPD
por: Soumagne, Thibaud, et al.
Publicado: (2023)

A pragmatic randomized controlled trial to improve inhaler technique using mHealth
por: Vanoverschelde, Anna, et al.
Publicado: (2020)

Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis
por: Edris, Ahmed, et al.
Publicado: (2019)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
por: Andreas, Stefan, et al.
Publicado: (2016)

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2021)

Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2023)

Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies
por: Vanoverschelde, Anna, et al.
Publicado: (2021)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Community pharmacist counseling improves adherence and asthma control: a nationwide study
por: Putman, Barbara, et al.
Publicado: (2022)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
por: Nicolini, Gabriele, et al.
Publicado: (2008)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

Inhaled glucocorticoid-induced metabolome changes in asthma
por: Daley-Yates, Peter, et al.
Publicado: (2022)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Development of a tool to detect small airways dysfunction in asthma clinical practice
por: Kocks, Janwillem, et al.
Publicado: (2023)

Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
por: Ojanguren, Iñigo, et al.
Publicado: (2021)

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
por: Bogart, Michael, et al.
Publicado: (2023)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
por: Halpin, David M.G., et al.
Publicado: (2021)

Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
por: Dransfield, Mark T., et al.
Publicado: (2021)

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
por: Barrecheguren, Miriam, et al.
Publicado: (2022)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Amazing pleiotropic effects of azithromycin
por: Lahousse, Lies
Publicado: (2018)

Epigenetic targets for lung diseases
por: Lahousse, Lies
Publicado: (2019)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthma
por: Singh, Dave, et al.
Publicado: (2023)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_33ld5p70okgvdrloek7de04915